[Problems of treatment of epilepsy].
D000748:Anemia, Macrocytic / Q000139:chemically induced; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D001965:Bromides / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004357:Drug Synergism; D004827:Epilepsy / Q000188:drug therapy* / Q000453:epidemiology; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D011044:Poland
D000927:Anticonvulsants; D001965:Bromides; D006827:Hydantoins; D010113:Oxyphenbutazone; D003975:Diazepam; D010634:Phenobarbital
Problematyka leczenia padaczki.